A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
Clinical trial NCT05583955 · COMPLETED
Trial details
- NCT number
- NCT05583955
- Sponsor
- Noema Pharma AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2023-10-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.